ADD/ADHD News

Longitudinal analysis indicated associations between extended use of stimulant medications and shorter adult height but not symptom reduction.

AEVI-001, an oral non-stimulant, did not meet its primary efficacy endpoint for ADHD, but did exhibit an encouraging trend in improvement at its highest dose, according to findings released by Aevi Genomic Medicine.

Parent-reported lifetime prevalence and comorbidity of asthma, attention deficit/hyperactivity disorder and autism spectrum disorder in children were differentially influenced by poverty status, according to recent study findings.

Individuals born at extremely low birth weight had higher risk for mental health problems in childhood, adolescence and adulthood, compared with peers born at normal birth weight.

Results from an international cross-sectional mega-analysis indicated differences in subcortical brain volume between individuals with ADHD and those without, as well as between children and adults with ADHD.

Shire recently announced that the FDA acknowledged receipt of a class 2 resubmission of a New Drug Application for SHP465, a triple-bead mixed amphetamine salts capsule, as a once-daily treatment for ADHD.

Sunovion Pharmaceuticals recently announced dasotraline, a dopamine and norepinephrine reuptake inhibitor, significantly improved ADHD in children aged 6 to 12 years.

Sunovion Pharmaceuticals recently announced dasotraline, a dopamine and norepinephrine reuptake inhibitor, met its primary efficacy endpoint for moderate-to-severe binge-eating disorder in adults, but did not meet its primary endpoint for ADHD in adults.

In 2014, an estimated 43.6 million adults aged 18 years or older, or 18.1% of all U.S. adults, had any mental illness in the past year, excluding substance use disorders, according to the NIMH.

The AAP’s Council on Early Childhood released a policy statement encouraging pediatricians to advocate for increased access to care and additional evidence-based therapies, especially nonpharmacological therapies, for children with emotional or behavioral problems.